Navigation Links
WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
Date:11/21/2011

85,025$

1,454,920Cost of revenue492,246312,047647,137583,796Gross profit (loss)(403,158)321,194(162,112)871,124Operating expenses:Sales and marketing913,948653,3222,550,1071,378,271Research and development1,900,4172,047,3675,980,3055,086,078General and administrative1,259,2111,248,7734,747,9923,452,727Total operating expenses4,073,5763,949,46213,278,4049,917,076Operating loss(4,476,734)(3,628,268)(13,440,516)(9,045,952)Other income and (expenses):Interest income6,8437,96514,20315,072Interest expense (including excess debt discount of $2,255,074 expensed as interest in the nine months ended September 30, 2011)(240,143)(280)(3,059,370)(1,954)Gain on revaluation of conversion element of Series B redeemable convertible preference shares of subsidiary, net35,615124,473111,227124,473Gain on revaluation of conversion element of convertible promissory notes, net7,525,265--5,912,152--Gain (loss) on revaluation of warrants, net1,064,096(1,665,950)1,363,70314,526Liquidated damages for late S-1 registration(532,161)--(532,161)--Miscellaneous income (expense)214,843(62,703)197,593(135,697)Total other income and (expenses)8,074,358(1,596,495)4,007,34716,420Net income (loss) before provision for income taxes3,597,624(5,224,763)(9,433,169)(9,029,532)Provision for income taxes16,703--(713)--Net income (loss)3,580,921(5,224,763)(9,432,456)(9,029,532)Accretion on Series A and B redeemable convertible preference shares of subsidiary associated with premium(166,773)(79,151)(287,929)(223,464)Accretion on Series B redeemable convertible preference shares of subsidiary associated with bifurcation of conversion element--(428,787)--(428,787)Accretion on Series A-1 convertible preferred stock associated with beneficial conversion feature----(9,250,009)--Series A-1 preferred dividend(191,866)--(266,119)--Net income (loss) attributable to common stockholders

$

3,222,282$

(5,732,701)$

(19,236,513)$

(9,681,783)Net income (loss) pe
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. WaferGen Announces Delay in Reporting of Second Quarter 2011 Results
2. WaferGen Announces $30 Million Financing
3. WaferGen and NuGEN Announce Agreement to Co-Develop Integrated Workflows Using SmartChip System and SPIA® for Single Cell Analysis, FFPE and Next Generation Sequencing
4. WaferGen Announces General Availability of Quick-Turnaround SmartChip Custom Panels
5. WaferGen Names Gary P. Schroth, Ph.D., as New SVP, Genomics Research and Applications
6. WaferGen Corporate Presentation to be Webcast at Rodman and Renshaws 12th Annual Healthcare Conference
7. WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System
8. WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip(TM) Nano-Dispenser with WaferGens SmartChip(TM) High-throughput Real-Time PCR System
9. WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Companys Scientific Advisory Board
10. WaferGen Closes on Private Financings of Approx. $6.2 Million
11. WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  The EveryLife ... Hatch (R-UT) and Amy Klobuchar ... Now Accelerating Cures & Treatments, or OPEN ACT. ... disease patient advocacy organizations, this bipartisan legislation promises ... affordable medicines to rare disease patients by incentivizing ...
(Date:5/21/2015)... 21, 2015 Patent Offering, The patent’s ... diagnostic or therapeutic imaging within a body lumen (open ... endoscope having a low cost, single-use disposable illumination and ... was October 18, 2013 and the patent approval was ... the physician to customize the lighting and magnification of ...
(Date:5/21/2015)... , May 20, 2015 Research and Markets ... addition of the "2015 Global Survey on ... offering. The primary goal of this ... cytometry instruments and reagents. Key information the survey ... selection of flow cytometers, predominantly used applications for ...
(Date:5/21/2015)... Prussia, PA (PRWEB) May 21, 2015 ... O’Neill has joined the firm as senior statistician and ... 30 years of experience in the management and analysis ... biologics, pharmaceutical and chemical industries. , “We’re delighted to ... longstanding capabilities in data analytics,” said Dr. Philippe Cini, ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3Global Survey on Flow Cytometry Adoption Trends 2015 2Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
... Acquisition Expected to Add New Drug Products to Aida Pharmaceuticals, ... ... MONICA, Calif., March 27 Aida,Pharmaceuticals, Inc. (OTC Bulletin Board: ... to acquire a controlling interest,in one of the leading microbiology ...
... Pharmasset, Inc.,(Nasdaq: VRUS ), a pharmaceutical company ... treat viral infections, is,pleased to announce the appointment ... the,Board of Directors and the Nominating and Corporate ... the Board of Directors of Sapphire,Therapeutics, a Director ...
... Led by OrbiMed Advisors, World,s Largest Healthcare ... ... a,bio-pharmaceutical company developing Anticalins(R), a novel class of,targeted human protein therapeutics, ... by new investor OrbiMed Advisors LLC, a major global fund dedicated,to ...
Cached Biology Technology:Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the People's Republic of China 2Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the People's Republic of China 3Pharmasset Appoints Herbert J. Conrad as a Director 2Pharmasset Appoints Herbert J. Conrad as a Director 3Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round 2Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round 3Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round 4
(Date:5/20/2015)... , May 20, 2015 NXT-ID, Inc. (NASDAQ: ... its wholly owned subsidiary, 3D-ID LLC, a company engaged ... Battelle for the biometrics technology portion of the recently ... from the Department of the Army. 3D-ID ... developed for government, law enforcement and security agencies. ...
(Date:5/18/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
(Date:5/11/2015)... , May 11, 2015  Through a well-rounded UAS ... had a strong showing at AUVSI,s Unmanned 2015 ... representatives of Ohio,s UAS industry met ... abroad from all points along the UAS ecosystem. ... Coalition,s (DDC) Vice President for Aerospace Rich Knoll . ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... Palo Alto, CA Researchers at the Carnegie Institution,s ... link in the so-called signaling pathway for plant steroid ... molecules that start at the cell surface and cascade ... the first such pathway in plants for which all ...
... for many a person this is the greatest of pleasures. ... we drink beer as it is among the most energy-intensive ... (TUM) are working hard to improve the energy balance of ... combination that would allow energy savings of up to 20% ...
... periodontitis, a form of gum disease, is an independent ... This suggests the need for increased efforts to prevent ... the risk of this form of cancer. "Prevent ... maintain good oral hygiene," said Mine Tezal, D.D.S., Ph.D., ...
Cached Biology News:Plants on steroids: Key missing link discovered 2Environmentally 'green' beer: Munich brewing engineers research energy savings 2Environmentally 'green' beer: Munich brewing engineers research energy savings 3Prevent periodontitis to reduce the risk of head and neck cancer 2
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
Sf21 cells derived from Spodoptera frugiperda ovarian cells are recommended for high-level production of recombinant proteins. Higher expression levels of some proteins are seen due to the larger ce...
... universal lysis buffer, PCR mix, DNA polymerase ... l volume PCR reactions. This system can ... positive rod and coccus bacteria, such as ... Aureus, Streptococcus Agalactiae, and etc. With the ...
...
Biology Products: